CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 55 filers reported holding CIDARA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $56,000 | +33.3% | 20,999 | +0.3% | 0.00% | – |
| Q4 2020 | $42,000 | -30.0% | 20,943 | -0.6% | 0.00% | – |
| Q3 2020 | $60,000 | -20.0% | 21,064 | +3.1% | 0.00% | – |
| Q2 2020 | $75,000 | +44.2% | 20,429 | +206.1% | 0.00% | – |
| Q1 2017 | $52,000 | -18.8% | 6,675 | +8.3% | 0.00% | – |
| Q4 2016 | $64,000 | -99.9% | 6,166 | -0.3% | 0.00% | – |
| Q3 2016 | $70,795,000 | +11.2% | 6,183 | +0.1% | 0.00% | – |
| Q2 2016 | $63,654,000 | +76.8% | 6,174 | +118.9% | 0.00% | – |
| Q1 2016 | $36,000,000 | -25.0% | 2,820 | 0.0% | 0.00% | – |
| Q4 2015 | $48,000,000 | +133233.3% | 2,820 | -0.2% | 0.00% | – |
| Q3 2015 | $36,000 | -99.9% | 2,825 | +0.1% | 0.00% | – |
| Q2 2015 | $39,564,000 | – | 2,822 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
| Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
| Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
| BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
| FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
| Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
| Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
| Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
| Prosight Management, LP | 245,764 | $578,000 | 0.30% |